KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Net Income towards Common Stockholders: 2015-2024

Historic Net Income towards Common Stockholders for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $404.4 million.

  • Medpace Holdings' Net Income towards Common Stockholders rose 15.25% to $111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.0 million, marking a year-over-year increase of 18.42%. This contributed to the annual value of $404.4 million for FY2024, which is 42.99% up from last year.
  • Medpace Holdings' Net Income towards Common Stockholders amounted to $404.4 million in FY2024, which was up 42.99% from $282.8 million recorded in FY2023.
  • In the past 5 years, Medpace Holdings' Net Income towards Common Stockholders ranged from a high of $404.4 million in FY2024 and a low of $145.4 million during FY2020.
  • For the 3-year period, Medpace Holdings' Net Income towards Common Stockholders averaged around $310.9 million, with its median value being $282.8 million (2023).
  • Data for Medpace Holdings' Net Income towards Common Stockholders shows a peak YoY surged of 44.74% (in 2020) over the last 5 years.
  • Medpace Holdings' Net Income towards Common Stockholders (Yearly) stood at $145.4 million in 2020, then grew by 25.08% to $181.8 million in 2021, then soared by 34.93% to $245.4 million in 2022, then rose by 15.26% to $282.8 million in 2023, then soared by 42.99% to $404.4 million in 2024.